Background: Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been published, which recommend the use of prophylactic heparins in patients with risk of venous thromboembolism (VTE). The aim of this study was the assessment of the prophylaxis of VTE and the adherence to accepted guideline recommendations throughout the hospital. Methods: A cross-sectional study was carried out in a teaching hospital after guidelines were implemented. Patients' risk factors of deep vein thrombosis, risk categories of patients, and prophylaxis used in different wards were recorded. Appropriate adherence to the guidelines was analysed. Results: Of 397 patients, prophylaxis was used in 231 patients (58%), and low-molecular-weight hep...
Aim: The aim is to assess risk and evaluate the usage of pharmacological thromboprophylaxis adhering...
Abstract A majority of deep vein thromboses identified in screening studies of hospitalized patients...
BACKGROUND: Chemoprophylaxis is recommended for medical patients at moderate to high risk of venous ...
BACKGROUND: Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been publ...
Abstract Background DVT is the main cause of death in hospitalized patients and thromboprophylaxis i...
Background Venous thromboembolism is a potentially fatal complication of hospitalisation, affecting ...
Objective: To review the published clinical data on prophylaxis for thromboembolism in order to deve...
OBJECTIVE: To determine the rate of use of prophylaxis for venous thromboembolism in high-risk hospi...
Background: Venous thromboembolism (VTE) represents a major public health problem in Australia and w...
Introduction: Venous thromboembolism (VTE) is an underestimated health problem. The administration o...
AbstractObjectiveRoutine thromboprophylaxis, despite its well-known effectiveness and the fact that ...
Background: Venous thromboembolism (VTE) is the third most common vascular disease. Medical inpatien...
Background: Prophylactic venous thromboembolism (VTE) strategies have the greatest impact on patient...
This study’s purpose was to describe compliance with established venous thromboembolism (VTE) prophy...
Abstract Background Venous thromboembolism prophylaxis has been shown to safely and cost-effectively...
Aim: The aim is to assess risk and evaluate the usage of pharmacological thromboprophylaxis adhering...
Abstract A majority of deep vein thromboses identified in screening studies of hospitalized patients...
BACKGROUND: Chemoprophylaxis is recommended for medical patients at moderate to high risk of venous ...
BACKGROUND: Consensus Conferences and Guidelines for deep vein thrombosis prophylaxis have been publ...
Abstract Background DVT is the main cause of death in hospitalized patients and thromboprophylaxis i...
Background Venous thromboembolism is a potentially fatal complication of hospitalisation, affecting ...
Objective: To review the published clinical data on prophylaxis for thromboembolism in order to deve...
OBJECTIVE: To determine the rate of use of prophylaxis for venous thromboembolism in high-risk hospi...
Background: Venous thromboembolism (VTE) represents a major public health problem in Australia and w...
Introduction: Venous thromboembolism (VTE) is an underestimated health problem. The administration o...
AbstractObjectiveRoutine thromboprophylaxis, despite its well-known effectiveness and the fact that ...
Background: Venous thromboembolism (VTE) is the third most common vascular disease. Medical inpatien...
Background: Prophylactic venous thromboembolism (VTE) strategies have the greatest impact on patient...
This study’s purpose was to describe compliance with established venous thromboembolism (VTE) prophy...
Abstract Background Venous thromboembolism prophylaxis has been shown to safely and cost-effectively...
Aim: The aim is to assess risk and evaluate the usage of pharmacological thromboprophylaxis adhering...
Abstract A majority of deep vein thromboses identified in screening studies of hospitalized patients...
BACKGROUND: Chemoprophylaxis is recommended for medical patients at moderate to high risk of venous ...